RP00584BLQ
Biotinylated Recombinant Human MS4A1/CD20 Protein
Size
£611.00
- SKU:
- RP00584BLQ
- Additional Names:
- B1|Bp35|CD20|CD20 receptor|CD20S7|CVID5|LEU-16|Ly-44|MS4A-1|MS4A1|MS4A2|S7
- Molecular Weight:
- 20-25 kDa
- Purity:
- ≥95%
- Storage Conditions:
- -70[o]C Aliquot. Avoid freeze/thaw cycles.
- Supplier:
- Abclonal
- Immunogen:
- Ile141-Ser188
- Formulation:
- Biotinylated Recombinant Human MS4A1/CD20 Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ile141-Ser188) of Human MS4A1/CD20 (Accession #P11836-1) fused with a C-His&Avi tag at the C-terminus.
- Species:
- Human
- Uniprot:
- P11836-1
- Synonyms:
- B-lymphocyte antigen CD20;B-lymphocyte cell-surface antigen B1;B-lymphocyte surface antigen B1;B1;Bp35;CD20;CD20 antigen;CD20 receptor;CVID5;FMC7;LEU-16;leukocyte surface antigen Leu-16;Membrane-spanning 4-domains subfamily A member 1;membrane-spanning 4-domains, subfamily A, member 1;S7
- Extra Details:
- B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.
- Shipping Conditions:
- Dry Ice